Page last updated: 2024-08-22

suritozole and triazoles

suritozole has been researched along with triazoles in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's7 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kane, JM; Moran, PM; Moser, PC1
Dudley, MW; Kane, JM; Kehne, JH; Miller, JA; Sorensen, SM1
Dudchenko, P; Holley, LA; Sarter, M1
Kane, JM; Sorensen, SM; Zwolshen, JM1
Hamm, RJ; O'Dell, DM1
Chmielewski, PA; Dudchenko, P; Holley, LA; Miller, JA; Sarter, M1
Bhargava, VO; Green, VI; Hutcheson, SJ; Miller, TD; Robbins, DK; Weir, SJ1

Trials

1 trial(s) available for suritozole and triazoles

ArticleYear
Pharmacokinetics of MDL 26479, a novel benzodiazepine inverse agonist, in normal volunteers.
    Biopharmaceutics & drug disposition, 1997, Volume: 18, Issue:4

    Topics: Administration, Oral; Adult; Antidepressive Agents; Dose-Response Relationship, Drug; GABA-A Receptor Agonists; Humans; Male; Middle Aged; Reference Values; Triazoles

1997

Other Studies

6 other study(ies) available for suritozole and triazoles

ArticleYear
Enhancement of working memory performance in the rat by MDL 26,479, a novel compound with activity at the GABAA receptor complex.
    Brain research, 1992, Jan-08, Volume: 569, Issue:1

    Topics: Animals; Antidepressive Agents; Dose-Response Relationship, Drug; Learning; Male; Memory; Rats; Rats, Inbred Strains; Receptors, GABA-A; Reference Values; Reinforcement, Psychology; Scopolamine; Triazoles

1992
MDL 26,479: a potential cognition enhancer with benzodiazepine inverse agonist-like properties.
    British journal of pharmacology, 1992, Volume: 107, Issue:1

    Topics: Animals; Behavior, Animal; Benzodiazepines; Binding Sites; Carbolines; Cognition; Convulsants; Diazepam; Flumazenil; Hemicholinium 3; Hippocampus; In Vitro Techniques; Male; Mice; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Triazoles

1992
Attenuation of muscarinic receptor blockade-induced impairment of spatial delayed alternation performance by the triazole MDL 26,479.
    Psychopharmacology, 1992, Volume: 109, Issue:1-2

    Topics: Animals; Antidepressive Agents; Cognition; Dose-Response Relationship, Drug; Male; Memory, Short-Term; Muscarinic Antagonists; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Receptors, Muscarinic; Scopolamine; Triazoles

1992
The effects of a potential antidepressant, 2,4-dimethyl-5-(3-fluorophenyl)-3H-1,2,4-triazole-3-thione, in an electrophysiological model responsive to desipramine.
    Neuropharmacology, 1990, Volume: 29, Issue:6

    Topics: Action Potentials; Animals; Antidepressive Agents; Desipramine; Electrophysiology; gamma-Aminobutyric Acid; Male; Models, Biological; Norepinephrine; Purkinje Fibers; Rats; Rats, Inbred Strains; Triazoles

1990
Chronic postinjury administration of MDL 26,479 (Suritozole), a negative modulator at the GABAA receptor, and cognitive impairment in rats following traumatic brain injury.
    Journal of neurosurgery, 1995, Volume: 83, Issue:5

    Topics: Animals; Brain Injuries; Drug Administration Schedule; Male; Memory; Memory Disorders; Parasympathetic Nervous System; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Space Perception; Time Factors; Triazoles

1995
Interactions between the effects of basal forebrain lesions and chronic treatment with MDL 26,479 on learning and markers of cholinergic transmission.
    Brain research, 1993, May-07, Volume: 610, Issue:2

    Topics: Animals; Antidepressive Agents; Autoradiography; Biomarkers; Body Weight; Choline O-Acetyltransferase; Conditioning, Operant; Hemicholinium 3; Ibotenic Acid; Immunohistochemistry; Learning; Neuromuscular Depolarizing Agents; Parasympathetic Nervous System; Piperidines; Prosencephalon; Rats; Rats, Sprague-Dawley; Stereotaxic Techniques; Synaptic Transmission; Triazoles

1993